Mexico pharmaceuticals and health care system reviewed

17 December 2010

Mexico's future health care expenditure hinges on the country's upcoming elections, scheduled for 2012, which predictably hold the key to a number of changes in government spending decisions.

The opposition Institutional Revolutionary Party, for example, has been campaigning for some months to have the estimated oil price (up from $63 per barrel) in the government’s budget adjusted higher, in order to free up the scope for overall spending in the 2011 budget.

Notwithstanding political grandstanding, however, Business Monitor International expects health care spending in Mexico to rise from 757.70 billion Mexican pesos ($56.15 billion) in 2009 to 1,011.72 billion pesos ($97.52 billion) by 2014, representing a compound annual growth rate (CAGR) of 5.95% in local currency terms and 11.67% in US dollars.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical